Lesson 4.2. CNS Depressants

0.0(0)
studied byStudied by 0 people
full-widthCall with Kai
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/149

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

150 Terms

1
New cards

Anxiety Disorders

group mental illness described as having significant levels of anxiety and fear that interfere with social and occupational functioning, but should not be associated to an exogenous factor or medical condition

2
New cards

Generalized anxiety disorder

Example of Anxiety disorders:

a. chronic abnormally high levels of anxiety

b. other examples

a = ?

3
New cards

Phobias, Social phobia, OCD, and PTSD

Example of Anxiety disorders:

a. chronic abnormally high levels of anxiety

b. other examples

b = ?

4
New cards

genetic

Anxiety disorder are not a._________ nor caused by b.____________, mostly it is associated with c.______________________.

a = ?

5
New cards

neural damage

Anxiety disorder are not a._________ nor caused by b.____________, mostly it is associated with c.______________________.

b = ?

6
New cards

GABA transmission

Anxiety disorder are not a._________ nor caused by b.____________, mostly it is associated with c.______________________.

c = ?

7
New cards

Gamma aminobutyric acid

meaning of GABA

8
New cards

GABA

major inhibitory neurotransmitter in the Central Nervous System (GABA A and GABA B)

9
New cards

heteropentameric

GABA Receptors is ______________ in structure that provides binding sites to different drug molecules.

10
New cards

Benzodiazepines and Non-Benzodiazepines GABA Agonist

Drugs that are Categoru

11
New cards

Benzodiazepine ring allosteric site

Benzodiazepines Mechanism of Action:

a. Benzodiazepine binds to the ___________________ to modulate Cl- conduction.

b. Benzodiazepine increases the binding rate of GABA to __________________.

c. Cl- hyperpolarizes the membrane, decreasing __________________.

a = ?

12
New cards

GABA A receptors

Benzodiazepines Mechanism of Action:

a. Benzodiazepine binds to the ___________________ to modulate Cl- conduction.

b. Benzodiazepine increases the binding rate of GABA to __________________.

c. Cl- hyperpolarizes the membrane, decreasing __________________.

b = ?

13
New cards

membrane firing

Benzodiazepines Mechanism of Action:

a. Benzodiazepine binds to the ___________________ to modulate Cl- conduction.

b. Benzodiazepine increases the binding rate of GABA to __________________.

c. Cl- hyperpolarizes the membrane, decreasing __________________.

c = ?

14
New cards

Flumazenil

Treatment for overdose of Benzodiazepines which is a competitive molecule for Benzod

15
New cards

CYP 3A4 and 2C19

Metabolism of Benzodiazepines (BZDs)

a. Phase 1 metabolism

b. diazepam and flurazepam

c. N-desmethyldiazepam, C1methyl, C4methylene of Class B BZDs

a = ?

16
New cards

N-dealkylation

Metabolism of Benzodiazepines (BZDs)

a. Phase 1 metabolism

b. diazepam and flurazepam

c. N-desmethyldiazepam, C1methyl, C4methylene of Class B BZDs

b = ?

17
New cards

C3 aliphatic hydroxylation

Metabolism of Benzodiazepines (BZDs)

a. Phase 1 metabolism

b. diazepam and flurazepam

c. N-desmethyldiazepam, C1methyl, C4methylene of Class B BZDs

c = ?

18
New cards

Benzodiazepine Pharmacophore

knowt flashcard image
19
New cards

Ring A

Benzodiazepine Structure-Activity Relationship

  • aromatic ring essential for binding and activity

20
New cards

electronegative group (Cl, F, Br)

Benzodiazepine Structure-Activity Relationship

Ring A

  • At C7, the presence of _________________________, increases drug activity

21
New cards

C6, C8, C9 substitution

Benzodiazepine Structure-Activity Relationship

Ring A

  • _______________________ significantly decreases drug activity

22
New cards

Ring B

Benzodiazepine Structure-Activity Relationship

  • 7 sided ring

23
New cards

small alkyl (Hydrogen and methyl) group at N1

Benzodiazepine Structure-Activity Relationship

Ring B

  • promotes receptor affinity and activity

24
New cards

Benzodiazepine Structure-Activity Relationship

Ring B

  • At C2, the presence of _______________________ i

25
New cards

-OH

Benzodiazepine Structure-Activity Relationship

Ring B

  • At C3, _______ (hydrophilic) promotes faster excretion = 

26
New cards

Ring C

Benzodiazepine Structure-Activity Relationship

  • C5-phenyl ring not required for activity

27
New cards

receptor binding

Benzodiazepine Structure-Activity Relationship

  • Ring C promotes hydrophobic and steric interaction for __________________

28
New cards

increases

Benzodiazepine Structure-Activity Relationship

Ring C

  • The presence of electron-attracting groups at ortho (C2’ or C6’) and diortho position (C2’ and C6’) _________ activity

29
New cards

decreases

Benzodiazepine Structure-Activity Relationship

Ring C

  • The presence of substitutions at para position (C1’ or C4’) __________ activity

30
New cards

Electron-rich ring (s-triazole/imidazole)

Benzodiazepine Structure-Activity Relationship

Annelation

  • ____________________at C1-C2 of Ring B increases Benzodiazepine affinity

31
New cards

-epam/-epates

suffix for Class A Benzodiazepine

32
New cards

-olam

suffix for Class B Benzodiazepine

33
New cards

Class A and B

Structure-Activity Relationship of Benzodiazepine:

a. Ring A, B, C are applicable for ______________

b. Annelation is applicable for ____________

a = ?

34
New cards

Class B

Structure-Activity Relationship of Benzodiazepine:

a. Ring A, B, C are applicable for ______________

b. Annelation is applicable for ____________

b = ?

35
New cards

Structure of Diazepam

knowt flashcard image
36
New cards

Diazepam

Examples of Benzodiazepines Anxiolytics:

  • prototype Class A drug

  • long-acting

  • has the greatest affinity

37
New cards

Structure of Lorazepam

knowt flashcard image
38
New cards

Lorazepam

Examples of Benzodiazepines Anxiolytics:

  • prototype Class A drug

  • presence of C3-OH

  • short-acting

39
New cards

Structure of Alprazolam

knowt flashcard image
40
New cards

Alprazolam

Examples of Benzodiazepines Anxiolytics:

  • prototype Class B drug

  • contains a triazole ring

41
New cards

Structure of Midazolam

knowt flashcard image
42
New cards

Midazolam

Examples of Benzodiazepines Anxiolytics:

  • prototype Class B drug

  • contains an imidazole ring

43
New cards

Non-BZD GABA Agonist

drugs that do not possess the BZD pharmacophore but exhibits anxiolytic and sedative/hypnotic activity thru other mechanism

44
New cards

zolpidem, eszopiclone, zaleplon

Non-BZD GABA Agonist Drugs

45
New cards

highly selective for alpha-GABA A receptor subtype

Mechanism of Action for Non-BZD GABA Agonist

46
New cards

Insomnia

Use of Non-BZD GABA Agonist

47
New cards

CYP 3A4, 1A2 and 2D6

Metabolism of Non-BZD GABA Agonist:

a. Phase 1 metabolism

b. Happens in zaleplon

a = ?

48
New cards

first-pass effect

Metabolism of Non-BZD GABA Agonist:

a. Phase 1 metabolism

b. Happens in zaleplon

b = ?

49
New cards

Structure of Zolpidem

knowt flashcard image
50
New cards

Zolpidem

Non-BZD GABA Agonist

  • prototype non-BZD

  • with an imidazopyridine ring

  • has 3 areas are essential for binding

51
New cards

R1

Zolpidem

  • electron-rich planar aromatic region

52
New cards

R2

Zolpidem

  • free rotating aromatic ring region

53
New cards

R3

Zolpidem

  • antiplanar region

54
New cards

electronegative group substitution

Structure-Activity Relationship of Non-BZD GABA Agonist (Zolpidem)

  • In R1/R3, _____________________ decreases activity.

55
New cards

Bulky N-substitution

Structure-Activity Relationship of Non-BZD GABA Agonist (Zolpidem)

  • In R3, _____________________ decreases activity.

56
New cards

Structure of Eszopiclone

knowt flashcard image
57
New cards

Eszopiclone

Non-BZD GABA Agonist

  • with cyclopyrrolone ring

  • binds at allosteric site of GABA A receptors

58
New cards

Structure of Zaleplon

<p></p>
59
New cards

Zaleplon

Non-BZD GABA Agonist

  • with pyrazolopyrimidine ring

  • -CN group provides receptor selectivity

60
New cards

Sedative/Hypnotics

  • drugs which depress or slow down the body’s function

  • its activity can range from calming to sleep promotion

61
New cards

Ascending Reticular Activating System (ARAS)

Arousal input in the body regulated by Glutamate

62
New cards

Tuberomammalian nucleus (TBN) and Suprachiasmatic nucleus (SCN)

facilitate wakefulness via different mechanisms

63
New cards

GABA A receptor

Sedative/ Hypnotics work primarily as:

a. ____________ agonist

b. __________________ system modulator

a = ?

64
New cards

histamine/melatonin

Sedative/ Hypnotics work primarily as:

a. ____________ agonist

b. __________________ system modulator

b = ?

65
New cards

Sedative/Hypnotics Drugs

BZDs, non-BZD GABAA agonist, barbiturates, melatonin receptor agonist, H1-receptor agonist

66
New cards

Barbiturates

agents of choice as sedative/hypnoticuntil theydeveloped tolerance, dependence and/or toxicity

67
New cards

ultra-short acting

Barbiturates can be:

a. less than 3 hours

b. 3-4 hours

c. 6-8 hours

d. 10-16 hours

a = ?

68
New cards

short-acting

Barbiturates can be:

a. less than 3 hours

b. 3-4 hours

c. 6-8 hours

d. 10-16 hours

b = ?

69
New cards

intermediate-acting

Barbiturates can be:

a. less than 3 hours

b. 3-4 hours

c. 6-8 hours

d. 10-16 hours

c = ?

70
New cards

long-acting

Barbiturates can be:

a. less than 3 hours

b. 3-4 hours

c. 6-8 hours

d. 10-16 hours

d = ?

71
New cards

sulfur

A barbiturates is ultra-short acting and is considered as an anesthetics which is characterized by the presence of:

72
New cards

alternating ketone (3) and nitrogen (2)

Structurally, barbiturates are characterized by:

73
New cards

binds to GABA A receptor

Mechanism of Action of Barbiturates:

a. __________________________ = increasing GABA binding

b. increased GABA binding increases _________________= reversible inhibition of excitatory neurons.

a = ?

74
New cards

Cl- ion transport

Mechanism of Action of Barbiturates:

a. __________________________ = increasing GABA binding

b. increased GABA binding increases _________________= reversible inhibition of excitatory neurons.

b = ?

75
New cards

liver metabolism

Metabolism of Sedative/Hypnotics:

a. significant ___________________

b. C5-substituent ____________

c. other metabolism

a = ?

76
New cards

oxidation

Metabolism of Sedative/Hypnotics:

a. significant ___________________

b. C5-substituent ____________

c. other metabolism

b = ?

77
New cards

glucuronidation and sulfation

Metabolism of Sedative/Hypnotics:

a. significant ___________________

b. C5-substituent ____________

c. other metabolism

c = ?

78
New cards

Barbituric Acid

Barbiturate pharmacophore

79
New cards

structure of Barbiturate pharmacophore

<p></p>
80
New cards

Acidic N and C5-H

Structure Activity Relationship:

Barbiturates

  • _____________________ results into inactivity

81
New cards

C5 substitution (except H)

Structure Activity Relationship:

Barbiturates

  • _____________ results to maximal activity

82
New cards

N1 and N3 alkyl substitution

Structure Activity Relationship:

Barbiturates

  • _______________ increases lipophilicity

83
New cards

anesthetics

Structure Activity Relationship:

Barbiturates

  • The replacement of =O with =S produces thiobarbiturates, ultra-short-acting agents,  which is used for __________________.

84
New cards

ethyl and phenyl

Structure Activity Relationship:

Barbiturates (C5 di-substitution)

a. it is long acting when the di-substitutions of C5 are:

b. it is intermediate acting when the di-substitutions of C5 are:

c. it is short acting when the di-substitutions of C5 are:

a = ?

85
New cards

ethyl or phenyl

Structure Activity Relationship:

Barbiturates (C5 di-substitution)

a. it is long acting when the di-substitutions of C5 are:

b. it is intermediate acting when the di-substitutions of C5 are:

c. it is short acting when the di-substitutions of C5 are:

b = ?

86
New cards

neither ethyl or phenyl

Structure Activity Relationship:

Barbiturates (C5 di-substitution)

a. it is long acting when the di-substitutions of C5 are:

b. it is intermediate acting when the di-substitutions of C5 are:

c. it is short acting when the di-substitutions of C5 are:

c = ?

87
New cards

branched

Structure-Activity Relationship

The following shortens Barbiturates’ duration of action when:

a. presence of __________ chains

b. presence of _____________ side chains

c. side chain is larger than the _________________

a = ?

88
New cards

unsaturated

Structure-Activity Relationship

The following shortens Barbiturates’ duration of action when:

a. presence of __________ chains

b. presence of _____________ side chains

c. side chain is larger than the _________________

b = ?

89
New cards

ethyl group

Structure-Activity Relationship

The following shortens Barbiturates’ duration of action when:

a. presence of __________ chains

b. presence of _____________ side chains

c. side chain is larger than the _________________

c = ?

90
New cards

Structure of Phenobarbital

knowt flashcard image
91
New cards

Phenobarbital

Examples of Barbiturates

  • long-acting agent due to the presence of ethyl and phenyl at C5

92
New cards

Structure of Butabarbital

knowt flashcard image
93
New cards

Butabarbital

Examples of Barbiturates

  • intermediate-acting agent due to the presence of ethyl at C5

94
New cards

Structure of Secobarbital

knowt flashcard image
95
New cards

Secobarbital

Examples of Barbiturates:

  • short-acting agents due to the presence of double bonds and branching

96
New cards

Structure of Thiopental

<p></p>
97
New cards

Thiopental

Examples of Barbiturates:

  • ultra short-acting agent used as an anesthetic due to the substitution of =S from =O

98
New cards

Melatonin Receptor Agonists

drugs which promotes sleep by binding into melatonin receptors in the brain (MT1R and MT2R)

99
New cards

Suprachiasmatic nucleus (SCN)

Mechanism of Action of Melatonin Receptor Agonists:

a. binds to MT1R decreasing ________________________ firing promoting sleep

b. binds to MT2R affecting __________________ (CNS clock)

a = ?

100
New cards

circadian rhythm

Mechanism of Action of Melatonin Receptor Agonists:

a. binds to MT1R decreasing ________________________ firing promoting sleep

b. binds to MT2R affecting __________________ (CNS clock)

b = ?